190 related articles for article (PubMed ID: 6774529)
1. [Immune response of guinea pigs to combined action of brucella vaccine and homologous lysed antigen].
Rementsova MM; Shin NG; Usmanova FI
Zh Mikrobiol Epidemiol Immunobiol; 1980 Mar; (3):72-5. PubMed ID: 6774529
[TBL] [Abstract][Full Text] [Related]
2. [Immunogenic properties of brucella protective antigen upon revaccination].
Dranovskaia EA; Vershilova PA
Zh Mikrobiol Epidemiol Immunobiol; 1976; (12):94-9. PubMed ID: 828826
[TBL] [Abstract][Full Text] [Related]
3. [Morphologic reactions in brucella infections in guinea pigs prevaccinated with cellular components of virulent brucellea].
Safronova VM; Baeva AA; Taran IF
Zh Mikrobiol Epidemiol Immunobiol; 1976; (3):73-6. PubMed ID: 822661
[No Abstract] [Full Text] [Related]
4. [Jet method of administration of live brucella vaccine].
Kniazeva ZN; Shavalov LP; Vermul MS
Zh Mikrobiol Epidemiol Immunobiol; 1978 Apr; (4):27-30. PubMed ID: 99922
[TBL] [Abstract][Full Text] [Related]
5. [A comparative study of the intensity of immunity created by vaccinal strains of Br. abortus 19, Br. melitensis Rev 1 and Br. suis 61 following their simultaneous and separate administration].
Kozlov MP; Zamakhaeva EI
Zh Mikrobiol Epidemiol Immunobiol; 1969 Aug; 46(8):25-31. PubMed ID: 4982998
[No Abstract] [Full Text] [Related]
6. [Changes in organs after vaccination with Br. abortus B-8 strain].
Iazykova KN; Erzh NI
Veterinariia; 1973 Apr; (4):41-2. PubMed ID: 4218919
[No Abstract] [Full Text] [Related]
7. Brucella abortus vaccines: comparison of protection provided by immunopotentiated 45/20 bacterins and live strain 19 vaccine in guinea pigs.
Woodard LF; Toone NM; Jasman RL
Am J Vet Res; 1981 Nov; 42(11):1959-62. PubMed ID: 6802042
[TBL] [Abstract][Full Text] [Related]
8. Immunization of BALB/c mice with a combination of four recombinant Brucella abortus proteins, AspC, Dps, InpB and Ndk, confers a marked protection against a virulent strain of Brucella abortus.
Hop HT; Arayan LT; Huy TXN; Reyes AWB; Min W; Lee HJ; Park SJ; Chang HH; Kim S
Vaccine; 2018 May; 36(21):3027-3033. PubMed ID: 29678458
[TBL] [Abstract][Full Text] [Related]
9. [Phenol-insoluble vaccine against human brucellosis: evaluation of the immunogenic power in guinea pigs].
Bolpe J; de Lapenta DF; García-Carrillo C
Rev Inst Med Trop Sao Paulo; 1991; 33(1):23-7. PubMed ID: 1843392
[TBL] [Abstract][Full Text] [Related]
10. The immunization of guinea-pigs and mice with a whole-culture extract of a smooth and a rough strain of Brucella abortus.
Keppie J; Witt K; Smith H
Br J Exp Pathol; 1972 Oct; 53(5):518-28. PubMed ID: 4628447
[TBL] [Abstract][Full Text] [Related]
11. Comparative study of the immunobiological properties of live brucellosis vaccines.
Salmakov KM; Fomin AM; Plotnikova EM; Safina GM; Galimova GM; Salmakova AV; Ivanov AV; Panin AN; Sklyarov OD; Shumilov KV; Klimanov AI
Vaccine; 2010 Oct; 28 Suppl 5():F35-40. PubMed ID: 20362201
[TBL] [Abstract][Full Text] [Related]
12. Immunization of guinea pigs with Salmonella delivered anti-Brucella formulation reduces organs bacterial load and mitigates histopathological consequences of Brucella abortus 544 challenge.
Lalsiamthara J; Lee JH
Vet Immunol Immunopathol; 2018 Jan; 195():40-45. PubMed ID: 29249316
[TBL] [Abstract][Full Text] [Related]
13. Intermediate rough Brucella abortus S19Δper mutant is DIVA enable, safe to pregnant guinea pigs and confers protection to mice.
Lalsiamthara J; Gogia N; Goswami TK; Singh RK; Chaudhuri P
Vaccine; 2015 May; 33(22):2577-83. PubMed ID: 25869887
[TBL] [Abstract][Full Text] [Related]
14. Brucella melitensis Rev. 1 and Brucella abortus 45-20 vaccines in goats: immunity.
Alton GG; Jones LM; García-Carrillo C; Trenchi A
Am J Vet Res; 1972 Sep; 33(9):1747-51. PubMed ID: 4626469
[No Abstract] [Full Text] [Related]
15. The immune response of guinea pigs and buffalo calves to the locally prepared Brucella abortus strain 19 vaccine.
Jamal SM; Afzal M; Ahmed S
Rev Sci Tech; 2003 Dec; 22(3):893-7. PubMed ID: 15005547
[TBL] [Abstract][Full Text] [Related]
16. Vaccination against bovine brucellosis with a low dose of strain 19 administered by the conjunctival route. I.--Protection demonstrated in guinea pigs.
Plommet M; Plommet AM
Ann Rech Vet; 1975; 6(4):345-56. PubMed ID: 821381
[TBL] [Abstract][Full Text] [Related]
17. [Immunobiological properties of the protective brucellosis antigen].
Dranovskaia EA; Vershilova PA; Grekova NA
Zh Mikrobiol Epidemiol Immunobiol; 1974 Sep; (9):66-70. PubMed ID: 4216217
[No Abstract] [Full Text] [Related]
18. PLGA (85:15) nanoparticle based delivery of rL7/L12 ribosomal protein in mice protects against Brucella abortus 544 infection: A promising alternate to traditional adjuvants.
Singh D; Somani VK; Aggarwal S; Bhatnagar R
Mol Immunol; 2015 Dec; 68(2 Pt A):272-9. PubMed ID: 26442664
[TBL] [Abstract][Full Text] [Related]
19. The use of laboratory animals in the potency test of Brucella abortus S.19 vaccine. Response of guinea-pigs to graduated doses of vaccine and challenge.
Thornton DH; Muskett JC
J Comp Pathol; 1972 Apr; 82(2):201-8. PubMed ID: 4625200
[No Abstract] [Full Text] [Related]
20. Protection of BALB/c mice against Brucella abortus 544 challenge by vaccination with bacterioferritin or P39 recombinant proteins with CpG oligodeoxynucleotides as adjuvant.
Al-Mariri A; Tibor A; Mertens P; De Bolle X; Michel P; Godefroid J; Walravens K; Letesson JJ
Infect Immun; 2001 Aug; 69(8):4816-22. PubMed ID: 11447155
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
